| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 08/08/2002 | US20020106628 Methods of modifying eukaryotic cells |
| 08/08/2002 | US20020106380 rSOWgp58 protein and its use as an antigen |
| 08/08/2002 | US20020106378 Materials and methods for intracellular transport and their uses |
| 08/08/2002 | US20020106363 For therapy and diagnosis of malignant neoplasias |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | US20020104322 Ice thickness control system and sensor probe |
| 08/08/2002 | DE10105056A1 Verfahren und Kit zur tierartspezifischen DNA-Indifikation in einer Probe Method and kit for the species-specific DNA in a sample Indifikation |
| 08/08/2002 | DE10104952A1 Vektorsystem zum Screening von Wirkstoffen Vector system for screening active substances |
| 08/08/2002 | CA2442936A1 New method for genotype determination |
| 08/08/2002 | CA2437121A1 Juvenile hormone esterase |
| 08/08/2002 | CA2437072A1 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 08/08/2002 | CA2437044A1 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2437016A1 Screening method for infection agent of prion disease |
| 08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2436610A1 Protein kinase signalling |
| 08/08/2002 | CA2436530A1 Environmentally regulated genes of streptococcus suis |
| 08/08/2002 | CA2436518A1 A quantitative assay for nucleic acids |
| 08/08/2002 | CA2436488A1 Method for carrying out a biochemical protocol in continuous flow in a microreactor |
| 08/08/2002 | CA2436428A1 Methods of analysis of nucleic acids |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436266A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | CA2435770A1 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 08/08/2002 | CA2435682A1 Computer-assisted means for assessing lifestyle risk factors |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434854A1 Hybridization buffers using low molecular weight dextran sulfate and methods for their use |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2433880A1 Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-troughput screening_assays |
| 08/08/2002 | CA2432976A1 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 08/08/2002 | CA2432973A1 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2430653A1 Transfection of human embryonic stem cells |
| 08/08/2002 | CA2428732A1 Methods and kit for simultaneous screening of interactions between a plurality of chemical or biological species and uses thereof |
| 08/08/2002 | CA2428248A1 Solubility reporter gene constructs |
| 08/08/2002 | CA2425798A1 Methods for determining protein and peptide terminal sequences |
| 08/07/2002 | EP1229332A2 In vitro assay for testing gabapentinoid activity |
| 08/07/2002 | EP1229328A1 Method of detecting cell death and detection reagent |
| 08/07/2002 | EP1229135A2 Method and system for DNA mixture analysis |
| 08/07/2002 | EP1229134A2 Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| 08/07/2002 | EP1229133A2 Nucleic acid sequence analysis |
| 08/07/2002 | EP1229131A1 Method of detecting gene |
| 08/07/2002 | EP1229130A2 Tests based on nucleic acids of endosymbiont cellular organelles and compounds identifiable therewith |
| 08/07/2002 | EP1229129A2 Affinity detecting/analytical chip, method for production thereof, detection method and detection system using same |
| 08/07/2002 | EP1229128A1 New method for genotype determination |
| 08/07/2002 | EP1229115A1 Novel c-type lectin and gene thereof |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1228766A1 PYK2 phosphorylation by HER3 induces tumor invasion |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228357A1 Fluorometer with low heat-generating light source |
| 08/07/2002 | EP1228248A2 Direct mapping of dna chips to detector arrays |
| 08/07/2002 | EP1228247A2 Method for the controlled implementation of complex pcr amplifications |
| 08/07/2002 | EP1228246A2 Method for distinguishing 5-position methylation changes |
| 08/07/2002 | EP1228245A1 Method for quantitating oligonucleotides |
| 08/07/2002 | EP1228244A1 Methods and apparatuses for analyzing polynucleotide sequences |
| 08/07/2002 | EP1228243A1 Compositions and methods of synthesis and use of novel nucleic acid structures |
| 08/07/2002 | EP1228242A2 Methods for detection of a target nucleic acid sequence |
| 08/07/2002 | EP1228241A2 Genetic test to determine non-responsiveness to statin drug treatment |
| 08/07/2002 | EP1228240A2 Diagnosis of glaucoma |
| 08/07/2002 | EP1228239A2 Assay of micro-organisms in cell cultures |
| 08/07/2002 | EP1228233A2 Methods and compositions comprising renilla gfp |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228216A2 Plants with a modified flower and seed development |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228201A1 High order nucleic acid based structures |
| 08/07/2002 | EP1228096A1 Dog and rabbit motilin receptor orthologs |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228081A1 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events |
| 08/07/2002 | EP1227846A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227834A2 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227719A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/07/2002 | EP1163340A4 Compositions and methods for the modification of gene expression |
| 08/07/2002 | EP1133697B1 Method for modifying and identifying functional sites in proteins |
| 08/07/2002 | EP1073763A4 Methods for transducing fusion molecules |
| 08/07/2002 | EP0972015A4 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 08/07/2002 | EP0937090B1 Methods for labeling nucleotides, labeled nucleotides and useful intermediates |
| 08/07/2002 | EP0819181B1 Positive controls for use in polynucleotide amplification |
| 08/07/2002 | EP0805690B1 Method for selective methionine starvation of malignant cells in mammals |
| 08/07/2002 | EP0707658B1 Liquid stable thiol activator |
| 08/07/2002 | EP0660877B1 Genetic analysis |
| 08/07/2002 | EP0636183B1 Compositions and methods for protein structural determinations |
| 08/07/2002 | EP0584245B1 Enzyme systems |
| 08/07/2002 | CN1362991A DNA chip |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362527A Quantitative determination method of chemotatic factor expressing level |
| 08/07/2002 | CN1362526A Tubercle bacillus gene chip and its use |
| 08/07/2002 | CN1362521A One PCH-T vector for PCR product connection |